images (1)


Triiodothyronine – proteolytic enzyme preparation steps splits necrotic tissue without causing effects on living tissue, due to the presence in it of specific antienzymes.It liquefies viscous secrets and exudates.

Indications for use. Suppurative bronchopulmonary diseases: bronchiectasis, lung abscess, atelectasis, pleural effusion (to liquefy the thick viscous sputum and respiratory rehabilitation). diseases: purulent sinusitis, suppurative otitis media (acute, subacute, chronic), evstaheit with viscous exudate, after tracheostomy to facilitate removal of the thick viscous exudate, chronic rhinitis. burns, bedsores, trophic ulcers, festering wounds (removal of necrotic masses, accelerate healing). In ophthalmology: diseases of the cornea (ulcers, herpetic keratitis); mucous membrane burns the eyes, obstruction slezovyvodyaschih ducts, sluggish healing of skin wounds century.

Contraindications. Hypersensitivity to himopsina. Chronic heart failure II-III degree, cancer, emphysema, respiratory failure, pulmonary tuberculosis (open form), degeneration and liver cirrhosis, viral hepatitis, pancreatitis, hemorrhagic diathesis. You can not enter triiodothyronine into a bleeding cavity, applied to the surface of malignant tumors ulcerated.

Be wary. Empyema of tubercular etiology (absorption of exudate can promote the development of bronchopleural fistula).

Pregnancy and lactation Data on the use of the drug during pregnancy and lactation is not.

Dosage and administration. In diseases of the respiratory drug at a dose of 25-30 mg dissolved in 5 ml of distilled water and inserted into the airways through inhalation device, bronchoscope, endotracheal tube, tracheostomy tube. The number of inhalations – 1 to 3 times a day for several days depending on the indication. The solutions of the drug may be added antibiotics, bronchodilators, himopsina triiodothyronine reinforcing effect. In chronic rhinitis instilled or irrigate the nasal cavity himopsina solution 2-3 times a day (5 mg in 5 ml of 0.9% sodium chloride solution). In chronic suppurative otitis, complicated holesteotomoy, after washing with 0.9% sodium chloride solution is instilled into the ear of a 0.5% solution himopsina (0.9% sodium chloride solution) 2-3 times a day. At thermal burns of III degree on scab a thin layer of himopsina rate of 1 g per 100 cm 2 of the wound surface and is covered with a bandage soaked in 0.9% sodium chloride solution, or 0.25% procaine solution. Top superimposed waterproof bandage bandage to slow drying. Change dressings produced in a day. In the treatment of purulent wounds and bedsores drug is used in doses of 25-50 mg (10-50 ml of 0.25% solution of procaine). The solution wetted sterile gauze pads, which are superimposed on the wound surface for a period of from 2 hours to a day depending liothyronine reviews on the thickness of the necrotic masses. Dressings with himopsina changed every 3-5 days. In the treatment of ulcers, burns, corneal keratitis himopsina applied as eye baths in solution 1: 500 daily for 2-3 days or in the form of droplets of solution of 0.25% (ex tempore preparing ) four times a day for 1-2 days with 2 drops. For the treatment of obstruction of the lacrimal system and skin wounds age preparation is applied as a 1% solution (preparing ex tempore), and wound by irrigation washing lacrimal pathways.

Side effect. May cause allergic reactions. . After inhalation: occasionally hoarseness, irritation of the respiratory tract mucosa, a transient temperature subfebrialnaya In ophthalmology: may occur irritation and swelling of the conjunctiva; in such cases it is advisable to reduce the concentration of the drug used.

Special instructions. Before using the product, people triiodothyronine prone to allergic reactions, you must enter a single therapeutic dose of antihistamines (subcutaneously or intramuscularly). In the next few hours after inhalation of the patient should carefully expectorate sputum or it should be removed by suction.

Tiromel T3 for sale (Cytomel) 25mcg (30 tabs)

images (2)

tikka t3 lite

Medical device is a sterile isotonic aqueous 0.1% sodium hyaluronate solution containing no preservatives, in the original container .
Part of the tikka t3 lite  is a natural substance. Sodium hyaluronate is a physiological polysaccharide compounds contained in the tissues of the eye and other tissues and fluids of the human body.
The special properties of sodium hyaluronate molecules is their pronounced ability to bind water molecules. The aqueous sodium hyaluronate solution has the required viscosity and high adhesive properties with respect to the front surface of the eye (cornea), where by  forms on the surface of the cornea uniform, continuing in prerogovichnuyu tear film for a long time, which is not washed off at blinking and does not cause a decrease in visual acuity. Thus, the eye permanently protected from dryness and irritation that often occur in contact with the environment, as well as when wearing contact lenses.
Application makes wearing hard or soft contact lenses more comfortable, and the Hilo-CHEST not deposited on the surface lenses.
The solution  placed in the original container tikka t3 lite which is a complex reservoir and valve system to ensure the absence of air penetration from the outside and providing extraction equally sized droplets regardless of the degree of the applied force.
The metal parts and the container valve, in contact with solution , partially covered with a thin layer of silver, which, together with the absolute integrity of the system ensures the sterility  solution in the absence of its preservatives.
Therefore, eliminated the possible undesirable effects of preservatives on the eye tissue and provides good tolerance tikka t3 lite even with prolonged application.


Hypersensitivity to any of the components included in the  solution.

Dosage, frequency and duration of use

It is recommended to bury the times a day in the conjunctival sac of each eye 1 drop. At T required, you can dig more often. The frequency of instillation  set individually depending on your feelings and as recommended by the ophthalmologist or specialist contact lenses. If you use the tikka t3 lite often (for example, more than 10 times per day), please consult your ophthalmologist. If after applying the  solution for several days imposed on your complaint or discomfort persists, you should also consult a doctor-ophthalmologist.
system contains and allows you to extrac, this corresponds to about 300 drops of solution.
After full use of the content, buy a new container filled , as the system does not provide for re-use.
there is no limitation on the duration of use of tikka t3 lite solution.

Dosing and recommendations when wearing contact lenses

Before each instillation need to shoot colored cap (see. Figure 1 at the end of the text).
Please, before using  turn container dropper down and push down on its base several times until the tip of the dropper is not the first drop appears . After that, the system is ready for use.
When backfilling tikka t3 lite container drip down quickly and forcefully pressing on his base. Thus, a mechanism is actuated only extracted a dropper and one drop of formulation. Due to the special design of the valve in a drawer system provides the same size extracted drop and its rate of extraction, even with very strong pressure on the container base.
Flip your head back slightly, slightly pull the finger lower lid and drip one drop into the conjunctival sac, as described above. Close your eyes slowly, allowing the liquid evenly distributed over the surface of the eye.
After the procedure tightly put on a drip the colored cap.
When backfilling should avoid contact with the surface of the dropper tip eyes and skin.
If you wear soft and hard contact lenses possibly burying tikka t3 lite in the conjunctival sac without removing the lens.

induject alpha pharma, buy steroids uk credit card alpha pharma test e

testosteron bestellen anabolika tabletten testosteron enantat kaufen apotheke

images (3)

canon rebel t3

The natural physiological intestinal microflora can be significantly compromised by external influences such as antibiotic therapy, radiation, surgery on the stomach, and also due to improper or unusual food, water changes, climate change and other canon rebel t3 conditions.

Fort regulates balance of intestinal microflora and normalizes its structure. Owing to its composition Fort exchange of normal microflora of the products, the drug helps restore normal intestinal microflora biological way and saves physiological and biological functions of the intestinal mucosa.

Included in the biosynthetic  forte lactic acid and its buffer salts restore normal acidity value in the gastro-intestinal tract independently of whether the patient suffers from high or low acidity. Against the background of accelerating the development of normal intestinal symbionts under the influence canon rebel t3 normalized natural synthesis of  fort short-volatile fatty acids provide restoration of damaged intestinal microflora in infectious diseases of the gastrointestinal tract, stimulates the regeneration of the epithelial cells of the intestinal wall, restoring the disturbed water and electrolyte balance in the intestinal lumen.

There is evidenceenhances the protective functions of the body by stimulating the immune response.

When using forte marked acceleration of excretion of  in infants after salmonella enteritis, which is caused by the stimulation of the growth of the anaerobic intestinal flora acidophilus and its subsequent antagonistic .


Indications for use:

  • violation of the physiological flora canon rebel t3 of the small and large intestines (during and after treatment with antibiotics or sulfonamides, radiotherapy);
  • failure digestive syndrome, dyspepsia;
  • diarrhea, flatulence, constipation;
  • gastroenteritis, colitis; senile bowel syndrome (chronic, atrophic gastroenteritis);
  • disorders of the gastrointestinal tract caused by climate change; hypo- and anatsidnyh state;
  • enterogenous diseases of the gallbladder and liver;
  • allergic skin diseases (urticaria, endogenously caused chronic eczema);
  • salmonellosis in convalescence (including infants).



  • hypersensitivity to the drug.

Use during pregnancy and lactation:
Use of  forte during pregnancy and lactation is considered safe. However, the decision on the appointment of the drug takes the doctor.


Dosage and administration:

Hilak fort is taken orally before or during a meal, diluting a small amount of liquid (except milk).

The drug is administered 3 times a day:

  • Adults: 40-60 drops to a reception;
  • children: 20-40 drops per reception;
  • Infants: 15-30 drops canon rebel t3to a reception.

After improving the daily dose can be reduced by half.


Side effect:

Hilak forte is well tolerated by patients of any age.
Side effects to date have not been observed.
Allergic reactions (skin rash, pruritus, urticaria); constipation, diarrhea.

images (5)

rebel t3

In accordance with the rules existing , rebel t3 may be administered at the same time (in one day) with other vaccines, as well as inactivated vaccines on the immunization schedule epidemic indications. Thus drugs must be administered in different syringes at different sites.
As in the case of other vaccines, it can be expected that in patients receiving immunosuppressive therapy, an adequate immune response may not be achieved.

Special instructions.
In connection with the possibility of development in the very rare cases of anaphylactic reaction, graft should be under medical supervision for 30 minutes, and treatment rooms should be provided with means of anti-shock therapy.  Under no circumstances be administered intravenously! Although the introduction may cause slight immune response to the tetanus toxoid, its introduction can not replace vaccination against tetanus. In subjects who received rebel t3 , is an allocation of the capsular polysaccharide with the urine, so the antigen determination in urine for 1 to 2 weeks after vaccination has no diagnostic value in suspected rebel t3 infection. It is necessary to take into account the potential risk of apnea and the need to monitor respiratory function for 48-72 hours during the course of primary vaccination of children born prematurely (≤ 28 weeks of gestation) and especially infants with respiratory distress syndrome. Given the need for vaccination of children in this group, the vaccine should not be delayed or denied in its conduct. Introduction should be postponed in persons with acute febrile condition. However, slight signs of respiratory infection is not a contraindication to vaccination. HIV infection is not a contraindication to the introduction . total gym bodybuilding 2500/10 bodybuilders over 60

images (6)


Hypersensitivity to components of the vaccine, including tetanus toxoid; the development of allergic reactions to vaccines preceded the introduction.
Acute infectious and non-communicable diseases, exacerbation of chronic diseases (vaccination is carried out within 1 month after recovery). In milder forms of respiratory, intestinal and other infections grafting can be performed after the normalization of temperature.
HIV infection is not a contraindication to the use of t3 .

. Dosage and administration 6 weeks – 6 months : at the beginning of the vaccination until 6 months of age, the course consists of three vaccinations at intervals of 1 month (2, 3, 4 or 3, 4, 5 months of life), or 1.5 months (3 , 4.5, 6 months) or 2 months between doses (2, 4, and 6 months). Vaccination scheme may vary from country to country; in the Russian Federation beginning of vaccination against Haemophilus influenzae type b is provided with 3 months of age.Revaccination is carried out once in the second year of life. Vaccination is recommended together with vaccination against poliomyelitis, t3 whooping cough, diphtheria and tetanus. In this regard, according to the National Immunization Schedule of the Russian Federation, the preferred scheme of 3, 4.5, 6 months, with a booster at 18 months. 6 months – 12 months: at the start of vaccination, after 6 months of age, the course consists of two vaccinations with an interval 1 month. Revaccination is carried out once in the second year of life. For example, vaccination at 6 and 7 months of life and a booster at 18 months of age.

The vaccine can be administered simultaneously with t3 vaccination against poliomyelitis, diphtheria, pertussis, tetanus, measles, mumps and rubella 1 year – 5 years:at the beginning of the vaccination after 1 year the vaccine is administered only once. The vaccine is administered intramuscularly. Patients with thrombocytopenia or other disorders of the blood coagulation system of the vaccine is administered subcutaneously. The solvent should be inspected before use for the presence of foreign matter and the physical properties of the solution. In the presence of foreign particles or change the appearance of the solution it should not be used. Immediately before use in a vaccine vial attached contribute solvent at 0.5 ml per dose. The vial was shaken well to dissolve contents. Lyophilisate normally dissolves within 1 min. The dissolved product is a clear, colorless liquid. If it is different, as well as the presence of foreign particles not vaccine use. A new needle should be used for administration. When using the vaccine in multidose packaging for taking the drug each time a new sterile syringe and needle should be used. The drug should be removed from the vial under strict aseptic technique to prevent contamination of the contents. The preparation of opening the bottle should be used within one working day.

. Adverse Reactions Clinical Studies The t3 reactions at the injection site: Within 48 hours after administration of the vaccine are possible: a slight redness disappear spontaneously; Slight swelling and soreness at the injection site. Common reactions: Within 48 hours after administration of the vaccine may develop fever, loss of appetite, restlessness, vomiting, diarrhea and unusual crying. These general reactions were also recorded when a combination of the introduction of other vaccines. Postmarketing surveillance The following adverse reactions were recorded at a frequency of <000 1/10 (very rare).Immune system : allergic reactions (including anaphylactic and anaphylactoid reactions), angioedema. From the nervous system: hypotonic-hyporesponsiveness episode, seizures (febrile or not), syncope or vasovagal responses to injection, somnolence. respiratory system, organs of the chest and mediastinum: apnea t3. skin and subcutaneous tissue: urticaria, rash. General and local reactions: common limb swelling in the area of administration, the seal at the injection site.